Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New inhibitors of dual specificity protein kinase TTK presented

April 4, 2011

Novel HSP 90 inhibitors synthesized at Nerviano Medical Sciences

April 4, 2011

Combination of HER2 and VEGF peptidomimetics block angiogenesis and tumor cell growth

April 4, 2011

Amgen requests reexamination of CHMP opinion on Vectibix with chemotherapy for mCRC

April 1, 2011

Novel tyrosine-protein kinase inhibitors patented by Chinese scientists

April 1, 2011

Nanodiamond-conjugated doxorubicin associated with enhanced efficacy and improved safety

April 1, 2011

Phase I data reveal protective effects for MnSOD-PL in chemoradiotherapy-treated NSCLC

April 1, 2011

Composite iMyD88/CD40 fusion protein shows enhanced antitumor activity

March 31, 2011

Natco Pharma receives FDA orphan drug status for NRC-AN-019

March 31, 2011

Amgen and Takeda report topline phase II results for motesanib in lung cancer

March 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...